Introduction
Coronary ischaemic syndromes, including chest pain suggestive of angina pectoris, and documented myocardial infarction, in the presence of angiographically normal coronary arteries, have been the subject of much attention. In contrast to atheromatous coronary artery disease the pathophysiology of such conditions is poorly understood and the mechanisms underlying myocardial ischaemia in these circumstances have been the cause of a great deal of conjecture and controversy.
Myocardial infarction
A small percentage of patients presenting with acute myocardial infarction are found to have angiographically normal epicardial coronary arteries. The prevalence is high in certain subsets of myocardial infarction patients, such as the very young,' especially those infarcting during or following severe physical exercise,2 and in young women during pregnancy or using oral contraceptives and smoking.3 Documented myocardial infarction in the presence of normal coronary arteries has been reported in thyrotoxicosis; both true and factitious,4 temporally related to cocaine use,5 after acute exposure to carbon monoxide, 6 and in patients with viral myocarditis.7 This issue of the Journal contains a case report on a multisystem vasculitis leading to myocardial infarction without evidence of coronary artery involvement. 8 Amongst suggested mechanisms are defects in clotting factors and platelet activity,9"10 coronary artery spasm," thrombosis with rapid spontaneous lysis,'2 coronary emboli' and small vessel disease. '3 In cases of chronic Chagas' heart disease, where there is parasympathetic ganglion destruction it is postulated that transitory sympathetic overdrive causes myocardial infarction. ' In these cases the coronary arteries are not only free of atheroma but indeed are larger in comparison to hypertensive and normal patients. Although various neural'9 and humoral202' mechanisms have been proposed, the genesis of coronary spasm is as yet undefined. Maseri and his co-workers postulate a focal hyperreactivity to a variety of coronary vasoconstrictive stimuli acting on different receptors.22 It has been observed that in variant angina, coronary spasm usually occurs at the site of atheromatous plaques,23 but the fact that such plaques are common and classical variant angina rare, suggests that some additional factor other than the presence of plaque is required. In a large study of patients with chronic coronary ischaemic syndromes other than variant angina, Bertrand et al. 24 showed that when stenosis existed there was no correlation between the degree of underlying stenosis and the occurrence of spasm. Bertrand could demonstrate ergonovine-induced angina in only 4% of those with chronic stable angina and 6% with old myocardial infarction. In contrast 20% ofpatients with recent infarction and 30% ofthose experiencing angina at rest developed focal coronary occlusion in response to ergonovine. It may be that in these acute situations there is a focal hyperreactivity to coronary vasoconstrictor agents.
Recent studies have shown that vasoactive compounds affect segments of the human coronary circulation differentially.22 This has implications in the pathophysiology of both focal coronary artery spasm and of 'Syndrome X', which has been suggested to be due to a more diffuse disturbance of coronary blood flow. Intracoronary injection of organic nitrates causes marked dilatation ofepicardial vessels, suggesting a resting coronary motor tone. In contrast these doses have little affect on total coronary blood flow, implying little effect on intramural resistance vessels. Adenosine displays the opposite pattern, with a marked distal dilating effect but relatively minor actions on the epicardial vessels.
Studies of the effects of intracoronary infusion of various endogenous vasoactive substances, including calcitonin gene related peptide,25 neuropeptide y,26 acetylcholine27 and substance P,28 point to a heterogeneity of responses within the human coronary circulation, and may allow some pharmacological intervention of coronary blood flow regulation. It is difficult to validate their relevance to the pathophysiology of conditions under consideration here.
The There have been several studies demonstrating an impaired rise in coronary blood flow in response to atrial pacing in patients with Syndrome X. In Cannon's studies38 patients developing their typical chest pain during atrial pacing demonstrated significantly lower great cardiac vein flow and higher calculated coronary resistance compared with those without pacing-induced chest pain. The chest pain group also demonstrated significantly higher lactate production and abnormalities of left ventricular systolic and diastolic function suggestive of myocardial ischaemia. These and other similar studies are consistent with a hypothesis that some patients with chest pain and angiographically normal epicardial arteries have dynamic abnormalities of the coronary microcirculation. This abnormal vasodilator capacity or vasoconstriction may result in angina pectoris and myocardial ischaemia. This has been termed microvascular angina.
If Syndrome X is due to small vessel disease, a pathogenesis is as yet unknown. No evidence of a structural abnormality of small arteries has ever been found, except in a small group of atypical patients who may have early cardiomyopathy.39 Conversely there is evidence that microvascular angina may give rise to cardiomyopathy. 40 Studies offorearm vasodilator reserve in normo- 
